drug_exposure_end_date

[Christian_Reich]

@bailey:

@bailey

e. OT1H, I can certainly understand that the people closest to the source have the best view of the data. OTOH, with a wide-open spec, standard analytics effectively can’t use this field at all, because there’s no common semantics.

Two points:

1. Well, we need to nail that. If you want to do analytics on drug exposure, you shouldn’t start having to do all sorts of guesswork on whether you trust the data or not. Maybe it’s true, and not all analytics are reasonable in a world like that. But remember: OMOP CDM is for aggregate research, not individual patient management. If there are one or two wrong spots - who cares.
2. We want to fix that exact problem in THEMIS: Which use cases, what convention. Please bring your use cases.